A citation-based method for searching scientific literature

Farak Ali, Shahnaz Alom, Anshul Shakya, Surajit K Ghosh, Udaya P Singh, Hans R Bhat. Arch Pharm (Weinheim) 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
100

Coronavirus Infections-More Than Just the Common Cold.
Catharine I Paules, Hilary D Marston, Anthony S Fauci. JAMA 2020
873
100

Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors.
Anshul Shakya, Rupesh V Chikhale, Hans Raj Bhat, Fatmah Ali Alasmary, Tahani Mazyad Almutairi, Surajit Kumar Ghosh, Hassna Mohammed Alhajri, Siham A Alissa, Shuchi Nagar, Md Ataul Islam. Mol Divers 2022
2
100


Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.
Haibo Zhang, Josef M Penninger, Yimin Li, Nanshan Zhong, Arthur S Slutsky. Intensive Care Med 2020
100

Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour, Danial Gholamin. J Biomol Struct Dyn 2021
13
100



Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study.
Md Arif Khan, Shafi Mahmud, A S M Rubayet Ul Alam, Md Ekhtiar Rahman, Firoz Ahmed, Mohammed Rahmatullah. J Biomol Struct Dyn 2021
21
100

Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine, Jerrine Joseph. J Biomol Struct Dyn 2021
175
100

An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets.
Liya Thurakkal, Satyam Singh, Rajarshi Roy, Parimal Kar, Sushabhan Sadhukhan, Mintu Porel. Chem Phys Lett 2021
20
100

Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
Ashish M Kanhed, Dushyant V Patel, Divya M Teli, Nirav R Patel, Mahesh T Chhabria, Mange Ram Yadav. Mol Divers 2021
32
100

Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2.
Gideon A Gyebi, Adegbenro P Adegunloye, Ibrahim M Ibrahim, Oludare M Ogunyemi, Saheed O Afolabi, Olalekan B Ogunro. J Biomol Struct Dyn 2022
20
100

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
Miao Gui, Wenfei Song, Haixia Zhou, Jingwei Xu, Silian Chen, Ye Xiang, Xinquan Wang. Cell Res 2017
350
100

Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.
Rupesh V Chikhale, Shailendra S Gurav, Rajesh B Patil, Saurabh K Sinha, Satyendra K Prasad, Anshul Shakya, Sushant K Shrivastava, Nilambari S Gurav, Rupali S Prasad. J Biomol Struct Dyn 2021
50
100

Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment.
Muhammad Shehroz, Tahreem Zaheer, Tanveer Hussain. Heliyon 2020
9
100

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
Jamshaid Ahmad, Saima Ikram, Fawad Ahmad, Irshad Ur Rehman, Maryam Mushtaq. Heliyon 2020
38
100



Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.
Atala B Jena, Namrata Kanungo, Vinayak Nayak, G B N Chainy, Jagneshwar Dandapat. Sci Rep 2021
50
100

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor.
Lei Wen, Kaiming Tang, Kenn Ka-Heng Chik, Chris Chun-Yiu Chan, Jessica Oi-Ling Tsang, Ronghui Liang, Jianli Cao, Yaoqiang Huang, Cuiting Luo, Jian-Piao Cai,[...]. Int J Biol Sci 2021
5
100

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
100

Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar, Sushabhan Sadhukhan. J Biomol Struct Dyn 2021
50
100



Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
100

In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
T Joshi, T Joshi, P Sharma, S Mathpal, H Pundir, V Bhatt, S Chandra. Eur Rev Med Pharmacol Sci 2020
71
100

Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan, Madhu Rathore. J Biomol Struct Dyn 2021
79
100

In silico assessment of potential leads identified from Bauhinia rufescens Lam. as α-glucosidase and α-amylase inhibitors.
Wadah Osman, Esraa M O A Ismail, Shaza W Shantier, Mona S Mohammed, Ramzi A Mothana, Abdelkhalig Muddathir, Hassan S Khalid. J Recept Signal Transduct Res 2021
3
100

Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study.
Vanderlan Nogueira Holanda, Elton Marlon de Araújo Lima, Welson Vicente da Silva, Rafael Trindade Maia, Rafael de Lima Medeiros, Arabinda Ghosh, Vera Lúcia de Menezes Lima, Regina Celia Bressan Queiroz de Figueiredo. J Biomol Struct Dyn 2022
6
100

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants.
Muhammad Tahir Ul Qamar, Safar M Alqahtani, Mubarak A Alamri, Ling-Ling Chen. J Pharm Anal 2020
429
100

Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
Hylemariam Mihiretie Mengist, Tebelay Dilnessa, Tengchuan Jin. Front Chem 2021
67
100


Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi. J King Saud Univ Sci 2020
22
100

Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study.
Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah Jane Niode, Fatimawali, Billy Johnson Kepel, Rinaldi Idroes, Yunus Effendi, Shahenur Alam Sakib, Talha Bin Emran. Scientifica (Cairo) 2020
65
100

A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.
Vincent J Munster, Marion Koopmans, Neeltje van Doremalen, Debby van Riel, Emmie de Wit. N Engl J Med 2020
664
100

In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.
Shilpa Chatterjee, Arindam Maity, Suchana Chowdhury, Md Ataul Islam, Ravi K Muttinini, Debanjan Sen. J Biomol Struct Dyn 2021
13
100

Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor.
Manish Kumar Tripathi, Pushpendra Singh, Sujata Sharma, Tej P Singh, A S Ethayathulla, Punit Kaur. J Biomol Struct Dyn 2021
53
100

In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.
Rajan Rolta, Rohitash Yadav, Deeksha Salaria, Shubham Trivedi, Mohammad Imran, Anuradha Sourirajan, David J Baumler, Kamal Dev. J Biomol Struct Dyn 2021
30
100

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
Qihui Wang, Yanfang Zhang, Lili Wu, Sheng Niu, Chunli Song, Zengyuan Zhang, Guangwen Lu, Chengpeng Qiao, Yu Hu, Kwok-Yung Yuen,[...]. Cell 2020
100

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).
Catrin Sohrabi, Zaid Alsafi, Niamh O'Neill, Mehdi Khan, Ahmed Kerwan, Ahmed Al-Jabir, Christos Iosifidis, Riaz Agha. Int J Surg 2020
100

The Cambridge Structural Database in retrospect and prospect.
Colin R Groom, Frank H Allen. Angew Chem Int Ed Engl 2014
587
100

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis.
Azza Hanif Harisna, Rizky Nurdiansyah, Putri Hawa Syaifie, Dwi Wahyu Nugroho, Kurniawan Eko Saputro, Firdayani, Chandra Dwi Prakoso, Nurul Taufiqu Rochman, Nurwenda Novan Maulana, Alfian Noviyanto,[...]. Biochem Biophys Rep 2021
11
100

Mechanisms of coronavirus cell entry mediated by the viral spike protein.
Sandrine Belouzard, Jean K Millet, Beth N Licitra, Gary R Whittaker. Viruses 2012
671
100


Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.
Vladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, Daniel L Cheney, Anzhi Wei, Joseph M Luettgen, Timothy M Harper,[...]. Bioorg Med Chem Lett 2016
5
100

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective.
Oludare M Ogunyemi, Gideon A Gyebi, Abdo A Elfiky, Saheed O Afolabi, Olalekan B Ogunro, Adegbenro P Adegunloye, Ibrahim M Ibrahim. Antivir Chem Chemother 2020
10
100


Potential for global spread of a novel coronavirus from China.
Isaac I Bogoch, Alexander Watts, Andrea Thomas-Bachli, Carmen Huber, Moritz U G Kraemer, Kamran Khan. J Travel Med 2020
165
100

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.
M Donoghue, F Hsieh, E Baronas, K Godbout, M Gosselin, N Stagliano, M Donovan, B Woolf, K Robison, R Jeyaseelan,[...]. Circ Res 2000
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.